AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.823
-0.027 (-3.21%)
Nov 7, 2024, 3:24 PM EST - Market open
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $32.51 million as of November 7, 2024. Its market cap has decreased by -84.23% in one year.
Market Cap
32.51M
Enterprise Value
44.84M
1-Year Change
-84.23%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since February 9, 2021, AEON Biopharma's market cap has decreased from $259.00M to $32.51M, a decrease of -87.45%. That is a compound annual growth rate of -42.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2024 | 33.60M | -87.44% |
| Dec 29, 2023 | 267.50M | -22.84% |
| Dec 30, 2022 | 346.70M | 3.49% |
| Dec 31, 2021 | 335.00M | 29.34% |
| Feb 9, 2021 | 259.00M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCure | 36.65M |
| Adagio Medical Holdings | 36.28M |
| Curis | 36.27M |
| Lumos Pharma | 35.87M |
| Lantern Pharma | 35.31M |
| Celularity | 34.08M |
| vTv Therapeutics | 34.06M |
| Concord Medical Services Holdings | 33.87M |